Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proactive Management of Outpatient Covid-19 Patients
2020-001752-17Phase 3Active
- Sponsor
- CHU Amiens-Picardie
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of azithromycin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Proportion of subjects still symptomatic at day 10. Started Apr 2020; status: active.
02
Drugs
azithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001752-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001752-17.